Le Lézard
Classified in: Health, Science and technology

BIOREM Announces Orders totalling $7.0 million and Order Backlog of $17 Million


GUELPH, ON, Dec. 13, 2017 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced several new orders totalling $7.0 million.  The orders are for air emission abatement projects in China and North America.

"Our focus for business development in 2017 has been primarily centered on China and we are beginning to see the results from all of that effort" said Derek S. Webb, President and Chief Executive Officer. "Of particular note are several high profile projects in the municipal wastewater and petrochemical refining industries in China.  Recent tightening of the air quality regulations in Tier 1 cities has resulted in a massive demand for effective long-term solutions."

"We are cooperating closely with our strategic partners and local regulators to capitalize upon this great opportunity and plan to continue to invest additional resources to ensure we maximize our market share in this fast growing economy.  Growth in China helps to supplement our core market areas in North America where we continue to grow year over year.  With these latest orders, the Company's order backlog stands firm at approximately $17 million, providing great revenue visibility for the next three to four quarters."

About BIOREM Inc.
BIOREM is a leading clean technology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). With sales and manufacturing offices across the continent, a dedicated research facility, a worldwide sales representative network and more than 1,100 installed systems worldwide, BIOREM offers state-of-the-art technology-based products and peace of mind for municipalities, industrial companies and their surrounding communities. Additional information on Biorem is available on our website at www.biorem.biz.

SOURCE Biorem Inc.


These press releases may also interest you

at 08:20
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has launched its Laboratory Automation Provider Program, enabling automation providers to readily support the adoption of Parse's...

at 08:15
Seed Health, a microbiome science company, today announced the appointment of Zain Kassam, M.D., M.P.H., as Chief Medical Officer. An award-winning physician-scientist, Dr. Kassam has played a pivotal role in the advancement of microbiome science for...

at 08:10
bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced David Elzi, Ph.D., has been named Vice President of...

at 08:10
Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced the availability of Over the Counter ("OTC") Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg, following Abbreviated New Drug Application ("ANDA") approval from the...

at 08:10
BigHat Biosciences, a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform announced a collaboration with Janssen Biotech Inc., a Johnson & Johnson company. This strategic...

at 08:10
Kiromic BioPharma, Inc. ("Kiromic" or the "Company") announces consistent favorable safety, tolerability, and efficacy from follow-up visits of the first cohort of three patients enrolled in the Company's Deltacel-01 Phase 1 clinical trial....



News published on and distributed by: